chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Very inflamed area beneath my injection site; fever of upto 102.2; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Very inflamed area beneath my injection site) and PYREXIA (fever of upto 102.2) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Very inflamed area beneath my injection site) and PYREXIA (fever of upto 102.2). At the time of the report, VACCINATION SITE SWELLING (Very inflamed area beneath my injection site) and PYREXIA (fever of upto 102.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: fever of upto 102.2 (High) fever of upto 102.2.         Treatment information not reported.   Concomitant medication not reported.   Reporter did not allow further contact
3/18/21 1:30 pm left arm pain, wrist joint pain. 8:00pm chills, warm, muscle and joint pain to both arms. Woke up 3 times during night to urinate, stomach ache. 5:00am 3/19/21moderate severe eye/face headache, had to take tylenol. woke up weak and diaphoretic. tired during morning , had to nap from 1-3pm. joint pain/headache returned at 8 pm requiring tylenol. 3/20/21 work up fine, no symptoms. then at 3 pm shakiness but only lasted few minutes. 3/21/21 work up 2am very anxious, read for an hour. work up at 630 feeling weird, very imbalance, had to hold onto furniture, increased with head movement, no pain. lasted about 2 hours. Insomnia has been continous since vaccine, 6-7 hours with interruptions. 4/5/21 bitter taste, foods taste different. eye pain intermittent since vaccine. finger joint pain (present prior to vaccine) seems to be worsening.
left inner thigh red sore & warm grapefruit size knot. Mom stated giving Tylenol advised to call MD & repeat back to ECHD.
Per pt's mom's report, reddish, pruritic rash appeared on right upper arm, outer aspect, on 9/7/00 or 9/8/00; initially, right deltoid area, then extended from approx. just below shoulder to just above elbow. No other local or systemic signs or symptoms. Seen by RN (vaccine administrator) on 9/13/00; papular, pinkish-white rash right, upper, outer arm; according to mother, rash almost completely gone on 9/17/00. Recommended treatment with ice, calamine lotion and diphenhydramine. Temperature was 98.2F on 9/13/00.
Vaccine given in the left deltoid. The left began to swell by 11/03/2010 at 3:48PM when the patient was seen in our office the patients arm was swollen from left scapula to wrist, the elbow was very swollen.  The skin was warm to touch and very tight with redness noted on the arm.
she developed flu-like symptoms after receiving the first dose of the vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "she developed flu-like symptoms after receiving the first dose of the vaccine".  Additional information: The patient and her husband received the first dose of the Pfizer Covid-19 vaccine on 24Feb2021 at (facility name withheld) and were due to receive their second dose on 17Mar2021 but have not received a call of confirmation from the facility yet. She was worried that they may not receive the second dose on time, compared to her neighbours who received their first dose later than they did get a confirmation call to receive their second dose already.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient developed induration of greater than 10 cm at site of injection. Patient had anesthesia in same hand and wrist. Patient experienced body pruritus. Patient was seen on 6/19/01 at which time the induration measured 4 cm.
100 temp 24 after shot, erythema tender (swollen started 3 days after shot , all erythema approximately 4cm disterl to shot site.
This spontaneous report as received from another health professional (Registered Nurse) refers to an approximately 19 year old female patient. Patient was not pregnant. Current conditions and medical history were reported as none. On 13-OCT-2014, the patient was vaccinated with VARIVAX (Merck) injection, lot number-K003412, expiry date-06-MAR-2016, 0.5 milliliter, subcutaneously. On 14-OCT-2014, the patient experienced, flat, light pink discoloration measuring 45 millimeter (mm) x 60mm in her left upper arm. In the center of the light pink discoloration was a darker pink discoloration measuring 15mm x 25mm. It was also reported that on 14-OCT-2014, patient had 2 out of 10 pain in the left arm. No treatment was given. No lab diagnostics studies performed. The outcome of 20 out of 10 pain in the left upper arm and discoloration was reported as recovering on 15-OCT-2014. Causality assessment was not reported. Product quality complaint was not reported. Additional information has been requested.
Extreme maculopapular, questionably pruritic rash sparing palms, soles and head. Fading on 3rd day. MMR #1 administered 1/10/02, rash began 1/21/02
pt devel severe diarrhea; V & dehydration; hosp for observation;disch;V recurred/diarrhea devel;stools greenish-yellow/& mucoid;pt became weak; hosp; Dx acute gastroenteritis, mod dehydration, oral intolerance & bacteriuria
headache; light-headedness/dizziness; neck swelling; extreme vertigo; he can't go to work; neurological type side effects; This is a spontaneous report from a contactable pharmacist. This pharmacist reported for a 52-year-old male consumer(patient). A 52-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and Expiration date was not reported), via an unspecified route of administration, on 06May2021, as a single dose for covid-19 immunization and  first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and Expiration date was not reported), via an unspecified route of administration, on 15Apr2021, as a single dose for covid-19 immunization. The patient medical history and concomitant medications was not reported. Caller stated that the patient has been having headaches, light-headedness and dizziness for 6 to 7 weeks. Caller also stated the patient has been experiencing neck swelling for the past two weeks, for which he is following up with an Ear, Nose, and Throat Specialist. Caller stated he has been having extreme vertigo, so much so that he can't go to work. He also has been having other neurological type side effects and the caller is thinking that she needs to do a VAERS report but also the patient's questions are more like if other people are reporting the same type of strange side effects that he thinks that he is having from the vaccine. Outcome of the events was unknown. Reporter seriousness for having extreme vertigo, so much so that he can't go to work, having other neurological type side effects was unspecified.  Information on the Batch/lot number has been requested.
Pfizer-BioNTech COVID- 19 Vaccine EUA: During post-vaccination observation period, vaccine recipient developed localized swelling and itchiness. They were monitored by EMS and took their own diphenhydramine.
skin condition; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SKIN DISORDER (non-serious), outcome "unknown", described as "skin condition". Therapeutic measures were taken as a result of skin disorder. Additional information: The patient said that she already took the first and second doses of the vaccine. The patient had a skin condition and she was using ointment (Corticosteroid) and she was not taking it orally. Patient was asking if she can take the booster shot.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Brain fog; Low grade fever; Feels very weak; Electrical pain headache/his head is still sore; This case was reported by a consumer via call center representative and described the occurrence of headache in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th January 2022, the patient received the 1st dose of Shingrix (intramuscular). On 5th January 2022, 1 hr after receiving Shingrix, the patient experienced headache and weakness. On 8th January 2022, the patient experienced low grade fever. On 18th January 2022, the patient experienced foggy feeling in head. The action taken with Shingrix was unknown. On 11th January 2022, the outcome of the low grade fever was recovered/resolved. On 17th January 2022, the outcome of the headache was recovered/resolved. On an unknown date, the outcome of the weakness and foggy feeling in head were not recovered/not resolved.   It was unknown if the reporter considered the headache, low grade fever, weakness and foggy feeling in head to be related to Shingrix.  Additional details were provided as follows: The reporter was the wife of the patient. The patient received Shingrix vaccine in the left arm. About 1 hour after receiving the Shingrix vaccine, the patient experienced an electrical pain headache which lasted about 12 days. Less than a day after vaccination, the patient felt very weak since getting the Shingrix vaccine which was not recovered. Three days after vaccination, the patient experienced a low-grade fever. The patient went to the emergency room on 12th January 2022 and they said, he was fine and sent him home. On the day of reporting, the patient stated his headache was gone but his head was still sore and he had some brain fog. The reporter did not consent to follow-up.
Patient received 2nd dose of the Moderna Covid vaccine on 4/24/21. On 5/3/21, patient called office complaining of redness, swelling, pain in left lower leg/calf. Patient was seen the same day and did have a STAT Ultrasound performed that did diagnose a DVT in the left leg.
Fever starting the morning after, about 102 by noon, took 2 Advil, fever down to about 101, then back to 102.8 about 9 PM.  99.5 morning of the second day, no ibuprofen, 100 at 2 PM.
Vomiting x 3 days Diarrhea x 1 day Decreased oral intake
Intense side effects/reactions more intense than with the second dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Intense side effects/reactions more intense than with the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Intense side effects/reactions more intense than with the second dose). At the time of the report, VACCINATION COMPLICATION (Intense side effects/reactions more intense than with the second dose) outcome was unknown.            No Concomitant product use was reported. No treatment information was provided.  It was reported that the patient had intense reactions with the second dose.   This case was linked to MOD-2021-392070 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Nov-2021: Follow up received contains non-significant information.
Pt presented to clinic with reddened, swollen, warm to touch (L) deltoid extending 1/2 way down biceps.
Shot was given at top of shoulder to high - my Dr said shot should have been lower and now my muscle has been affected - next looking at physical therapy.
Had expected symptoms of lightheadedness, fatigue, headache and arm soreness at injection site for 2 days after the vaccine.  Symptoms resolved but then recurred 1 week after the vaccine but more severe.  Profound lightheadedness and incapacitating fatigue with recurrence of headache for 3 days (days 7-10 post vaccine).  Difficulty thinking clearly during this time.  TMax 100.  Resulted in 2 days could not work in the Emergency Department.  COVID test was negative.
Very cold; Feels achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history provided.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired). At the time of the report, NASOPHARYNGITIS (Very cold), MYALGIA (Feels achy) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
pt exp episode of apnea w/cyanosis less than 2 hr p/inj; pt was seen @ ER & monitored for 24 hr then discharged;
pressure on her chest; headache/ bad headache; cold symptoms; sinus pain; This is a spontaneous report from a non-contactable consumer (patient) via a medical information team. A female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unknown date in 2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date in the patient experienced pressure on her chest, bad headache, cold symptoms and sinus pain. All of it went away yesterday. However, she is still experiencing the headache. Patient was due to get the second dose. Her daughter got tested for COVID-19 since possibly exposed to the virus. Therefore, the patient may have been exposed too. The outcome of the event headache was not recovered, and rest events was recovered on an unspecified date.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Initial information received on 16-Oct-2018 regarding an unsolicited valid non-serious case received from an other health professional via other company (Pfizer). This case involves a 65 years old female patient (96.62 kg) who experienced costochondritis, severe chest pain, swollen lymph nodes under the arm, flu and feeling sick and fell and broke arm, while she received vaccines PREVNAR 13, INFLUENZA VACCINE and DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route. On an unknown date, the patient received a dose of suspect PREVNAR 13 not produced by Sanofi Pasteur lot number not reported. On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE produced by unknown manufacturer lot number not reported. On an unknown date, the patient developed a non-serious costochondritis following the administration of DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE, following the administration of INFLUENZA VACCINE and following the administration of PREVNAR 13. On an unknown date, the patient developed a non-serious severe chest pain (chest pain) following the administration of DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE, following the administration of INFLUENZA VACCINE and following the administration of PREVNAR 13. On an unknown date, the patient developed a non-serious swollen lymph nodes under the arm (lymphadenopathy) following the administration of DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE, following the administration of INFLUENZA VACCINE and following the administration of PREVNAR 13. On an unknown date, the patient developed a non-serious flu and feeling sick (malaise) following the administration of DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE, following the administration of INFLUENZA VACCINE and following the administration of PREVNAR 13. On an unknown date, the patient developed a non-serious fell and broke arm (upper limb fracture) following the administration of DIPHTHERIA, TETANUS AND NOS PERTUSSIS VACCINE, following the administration of INFLUENZA VACCINE and following the administration of PREVNAR 13. (Other relevant tests included No lab data.) Final diagnosis was fell and broke arm, flu and feeling sick, swollen lymph nodes under the arm, severe chest pain and costochondritis. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Recovered / Resolved on an unknown date for costochondritis, as Recovered / Resolved on an unknown date for severe chest pain, as Unknown for swollen lymph nodes under the arm, as Unknown for flu and feeling sick and as Unknown for fell and broke arm. List of documents held by sender: none.
Red and sore at injection site - by next day April 2, 2021 Fatigue - by next day April 2, 2021 Nausea - by next day, though not the worst symptom which was next morning  Extremely light-headed, woozy and collapsed - fortunately on rug and though bruised on face and sore neck did not break anything (April 3, 2021 at about 8:00 am - second day after shot
On about 4/10/2021  (about 6 weeks after second COVID-19 vaccination) manageable pain at injection site came back. On 4/17/2021 pain came back with a vengeance (10 on pain scale) and therefore could not move arm.  In evening unbearable pain at injection site and numbness below elbow, like tourniquet on, plus some jaw pain, so went to ER.
1 week - weakness in legs, shuffling fast. 2 weeks - chills, extreme tiredness. 4 weeks - extreme chills, tiredness, backaches. 6 weeks - extreme backaches, falling down, paralysis, GBS.
SEVERE HEADACHES; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported on right deltoid, batch number: 1805028, and expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 for prophylactic vaccination. Concomitant medications included ibuprofen. On MAR-2021, the subject experienced severe headaches. On MAR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the severe headaches and chills was not reported. This report was non-serious.
This spontaneous report was received from a pharmacist regarding an unspecified number of patients of unknown age. There was no information about concurrent condition and historical medication. On an unknown date the patients were vaccinated with improperly stored PNEUMOVAX 23 lot # L007720, expiration date 08-JUL-2016. No adverse event was reported. No concomitant medication was reported. The outcome of the event was unknown. Additional information is not expected because reporter does not want to get contacted.
Post vax, the pt developed severe pain, swelling, red streaks across arm; sore under arm.
Minor breakthrough jaw pain(twinges like a sensitive tooth pain and not the "electrical" type pain of my TN) but on opposite side-Right side while eating and drinking. Headache a little worse than my "normal" type. Could just be my system dealing with the normal process of getting a vaccine. Not concerned enough at this time to get further testing or a doctor visit.
Three days after vaccine I developed a pain in my through when I swallowed, yawned, took deep breaths. Pain would not go away. Went for thyroid ultra sound which showed inflammation of thyroid right at the spot I  feel the pain. Experiencing extreme fatigue and rapid heart rate.
Case number PHEH2013US014194, is an initial spontaneous report received from a nurse on 27 Jun 2013. This case refers to a 16-year-old female patient. Her medical history and concomitant medication were not provided. She was vaccinated with MENVEO, (batch number: M12118 and expiry date: Aug 2014), at a dose of 0.5 ml intramuscularly on 19 Jun 2013. Reporter stated that, MENVEO vaccine was stored at 11F on 19 Jun 2013 and does not know if vaccine was frozen. No adverse event was reported following this administration error.
Diffuse abdominal pain onset approximately 10-12 hr post dose.  I was initially awoken that first night with nausea and abdominal pain. This continued through 1/22/21. My nausea had subsided and I was able to eat in small quantities. My abdomen felt bloat with mild distention. The AM of 1/23/21, I awoke and the diffuse abdominal pain had abated. I was left with RLQ abdominal pinpoint pain. This became progressively worse throughout the day. I presented to the ER on 1/23/21. Chem panel was normal. CBC also normal.   I received an abdominal CT scan with IV contrast for R/O appy. My appendix was normal. The scan revealed a serosal venous thrombophlebitis wth inflammation in the mesentery and transverse colitis.  The pain continued to progress, so I presented to the ER again on 1/25/21.  I received another abdominal CT along with additional lab work.  Lactate normal. D-Dimer mildly elevated at 0.7 and CRP was 9.7. Again CBC was normal. This CT did not reveal the micro-emboli or colits but rather omental inflammation.  At this point, surgery was consulted along with hematology for opinion regarding anticoagulation. The decision to anti coagulate was deferred. The diagnosis I received was omental infarct.  I remain on pain medications and continue to monitor for changes in my pain and a fever.
Received vax at about 17:30 on 3/26/02. States signs and symptoms started about 22:00 on 3/26/02. His left arm was "red and hot", "swollen down to elbow", "itchy, no rash" and "stiff". Tx: Instructed to take Advil with food. Apply ice and elevate. On 4/1/02 his wife stated, "It looks great". Pt denied previous pneumonia vax when asked. When entering vax into computer, (it was noted that the pt had received pneumonia vax in 1996, 2000 and now in 2002.
Woke up this morning with a massive headache that felt like my head was being stepped on, body aches, fatigue, nausea, and a fever of 101